(Q46576498)

English

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

scientific article published on 23 May 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

enzyme replacement therapy

0 references

mucopolysaccharidosis VI

1 reference

based on heuristic

inferred from title

Robert D. Steiner

14

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Ida Vanessa D Schwartz

3

object named as

Ida Vanessa D Schwartz

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Roberto Giugliani

2

object named as

Roberto Giugliani

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

1

object named as

Paul Harmatz

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

David Ketteridge

11

object named as

David Ketteridge

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Nathalie Guffon

4

object named as

Nathalie Guffon

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Elisa Leão Teles

5

object named as

Elisa Leão Teles

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Stuart J Swiedler

18

object named as

Stuart J Swiedler

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

7

object named as

J Edmond Wraith

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

9

object named as

Laila Arash

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Maurizio Scarpa

10

object named as

Maurizio Scarpa

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

13

object named as

Barbara Plecko

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Chester B Whitley

15

object named as

Chester B Whitley

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

16

object named as

Paige Kaplan

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

19

object named as

Celeste Decker

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

12

object named as

John J Hopwood

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

author name string

M Clara Sá Miranda

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Michael Beck

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Zi-Fan Yu

17

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

MPS VI Study Group

20

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

publication date

23 May 2008

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

94

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

469-475

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Management guidelines for mucopolysaccharidosis VI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

The six-minute walking test in children with cystic fibrosis: reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Six-minute walking test to assess exercise tolerance and cardiorespiratory responses during training program in children with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Six-minute walk test in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Replacement therapy in Mucopolysaccharidosis type VI: advantages of early onset of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.04.001

7 January 2021

Identifiers

10.1016/J.YMGME.2008.04.001

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/18502162

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46576498&oldid=2119069860"